Curanex Pharmaceuticals Inc cotiza a 4.88 USD y tiene una capitalización bursátil de $8M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty live…
| Métrica | CURX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -37.7% | -40.4% | +2.7% |
| ROA | -36.5% | -32.0% | -4.5% |
| Current Ratio | 81.93 | 2.84 | +79.09 |
| Debt / Equity | — | 0.28 | — |